IWC
SLDB icon

Integrated Wealth Concepts’s Solid Biosciences SLDB Stock Holding History

Integrated Wealth Concepts’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21K Buy
+221
New +$1.68K ﹤0.01% 5319

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Integrated Wealth Concepts's SLDB Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Solid Biosciences (SLDB) in Q2 2026: 221 shares worth $2.21K. The stake represents ﹤0.01% of the portfolio and ranks #5319 among its holdings.

156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Integrated Wealth Concepts held 221 shares of Solid Biosciences worth $2.21K as of Q2 2026.
  • Solid Biosciences was a new Integrated Wealth Concepts position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5319 holding.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.